Prudhvi Regula
Allergy & Immunology · Waterloo, IANPI 1386139244
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Sanofi at 32.7% of the total.
Across 76 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$455
- AstraZeneca$261
- Regeneron Healthcare Solutions, Inc.$205
- GSK$134
- Novartis$60
- CSL Behring$57
- plus $221 from 7 others
What the payments were for
- Food & beverage$1,38499%
- Education$81%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 31 | $455 |
| AstraZeneca | 14 | $261 |
| Regeneron Healthcare Solutions, Inc. | 7 | $205 |
| GSK | 8 | $134 |
| Novartis | 3 | $60 |
| CSL Behring | 2 | $57 |
| Amgen | 3 | $53 |
| Genentech USA, Inc. | 2 | $37 |
| Galderma Laboratories, L.p. | 2 | $37 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| Biocryst US Sales Co., LLC | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
How this compares
$1,392 in reported general payments places this provider in the 65th percentile of 32 allergy & immunology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $46,002 |
| Azelastine Hcl | 37 | $1,208 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $948 |
| Fluticasone Propionate | 41 | $476 |
| Montelukast Sodium | 51 | $159 |
| Prednisone | 22 | $80 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Waterloo
- Felipe JavierWaterloo$750
- Vuong NayimaWest Des Moines$34K
- Fadi AlkhatibWest Des Moines$16K
- Daniel HamilosMason City$11K
- Lyla SchweigerCedar Rapids$6K
- Edward NassifAmes$5K
- Holly BrownCedar Rapids$4K
- Whitney MolisDes Moines$4K
- Safia NawazDes Moines$4K
- Andrea JonesDavenport$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.